BRUCE RICHMAN: Open Payments
NPI 1609927441 · QUAKERTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,395 in 171 payments from 31 companies in 2025. Trend: 2023 $2,522 · 2024 $2,924 · 2025 $3,395
Food & beverage: $3,355Education: $40
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 15 | $385 |
| Supernus Pharmaceuticals, Inc. | 14 | $278 |
| ABBVIE INC. | 13 | $245 |
| AstraZeneca Pharmaceuticals LP | 14 | $243 |
| Lilly USA, LLC | 12 | $209 |
| Amgen Inc. | 12 | $201 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $191 |
| Bayer Healthcare Pharmaceuticals Inc. | 8 | $189 |
| Exact Sciences Corporation | 8 | $171 |
| Xeris Pharmaceuticals, Inc. | 8 | $148 |
Products named: Qelbree, Wegovy, CAPLYTA, Kerendia, VRAYLAR, Cologuard Collection Kit, MOUNJARO, RECORLEV.
Industry payments across PA — which companies pay providers there.
